2-Deoxy-d-glucose attenuates isoflurane-induced cytotoxicity in an in vitro cell culture model of H4 human neuroglioma cells

Anesthesia and Analgesia

Volumn 113, Issue 6, 2011, Pages 1468-1475

  Zhang, Jun ^a   Dong, Yuanlin ^a   Xu, Zhipeng ^a   Zhang, Yiying ^a   Pan, Chuxiong ^a   McAuliffe, Sayre ^a   Ichinose, Fumito ^a   Yue, Yun ^b   Liang, Weimin ^c   Xie, Zhongcong ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE; CALCIUM; CASPASE 3; DEOXYGLUCOSE; ISOFLURANE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ARTICLE; CYTOTOXICITY; ENZYME ACTIVATION; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

CELL LINE, TUMOR; CYTOPROTECTION; CYTOTOXINS; DEOXYGLUCOSE; GLIOMA; HUMANS; ISOFLURANE; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 82255162752     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31822e913c     Document Type: Article

References (41)

1. Tanzi RE, Bertram L. Twenty years of the Alzheimers disease amyloid hypothesis: a genetic perspective. Cell 2005;120:545-55 (Pubitemid 40269768)
2. Selkoe DJ. Alzheimers disease: genes, proteins, and therapy. Physiol Rev 2001;81:741-66
3. Xie Z, Tanzi RE. Alzheimers disease and post-operative cognitive dysfunction. Exp Gerontol 2006;41:346-59
4. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B. Caspase signalling controls microglia activation and neurotoxicity. Nature 2011;472:319-24
5. Mattson MP. Contributions of mitochondrial alterations, resulting from bad genes and a hostile environment, to the pathogenesis of Alzheimers disease. Int Rev Neurobiol 2002;53: 387-409
6. Raina AK, Hochman A, Ickes H, Zhu X, Ogawa O, Cash AD, Shimohama S, Perry G, Smith MA. Apoptotic promoters and inhibitors in Alzheimers disease: who wins out? Prog Neuropsychopharmacol Biol Psychiatry 2003;27:251-4 (Pubitemid 36351492)
7. Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, Wei W, Pidikiti R, Keller JM, Eckenhoff MF. Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 2004;101:703-9 (Pubitemid 39121650)
8. Wei H, Kang B, Wei W, Liang G, Meng QC, Li Y, Eckenhoff RG. Isoflurane and sevoflurane affect cell survival and BCL- 2/BAX ratio differently. Brain Res 2005;1037:139-47 (Pubitemid 40362390)
9. Xie Z, Dong Y, Maeda U, Alfille P, Culley DJ, Crosby G, Tanzi RE. The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 2006;104:988-94
10. Xie Z, Dong Y, Maeda U, Moir RD, Xia W, Culley DJ, Crosby G, Tanzi RE. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. J Neurosci 2007;27:1247-54
11. Xie Z, Culley DJ, Dong Y, Zhang G, Zhang B, Moir RD, Frosch MP, Crosby G, Tanzi RE. The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo. Ann Neurol 2008;64:618-27
12. Zhang G, Dong Y, Zhang B, Ichinose F, Wu X, Culley DJ, Crosby G, Tanzi RE, Xie Z. Isoflurane-induced caspase-3 activation is dependent on cytosolic calcium and can be attenuated by memantine. J Neurosci 2008;28:4551-60
13. Tang J, Eckenhoff MF, Eckenhoff RG. Anesthesia and the old brain. Anesth Analg 2010;110:421-6
14. Bittner EA, Yue Y, Xie Z. Brief review: anesthetic neurotoxicity in the elderly, cognitive dysfunction and Alzheimers disease. Can J Anaesth 2011;58:216-23
15. Wei H, Liang G, Yang H, Wang Q, Hawkins B, Madesh M, Wang S, Eckenhoff RG. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5- trisphosphate receptors. Anesthesiology 2008;108:251-60 (Pubitemid 351156735)
16. Wei H, Xie Z. Anesthesia, calcium homeostasis and Alzheimers disease. Curr Alzheimer Res 2009;6:30-5
17. Zhang Y, Dong Y, Wu X, Lu Y, Xu Z, Knapp A, Yue Y, Xu T, Xie Z. The mitochondrial pathway of anesthetic isofluraneinduced apoptosis. J Biol Chem 2010;285:4025-37
18. Lee J, Bruce-Keller AJ, Kruman Y, Chan SL, Mattson MP. 2-Deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: evidence for the involvement of stress proteins. J Neurosci Res 1999;57:48-61 (Pubitemid 29293579)
19. Duan W, Mattson MP. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinsons disease. J Neurosci Res 1999;57:195-206 (Pubitemid 29300322)
20. Xie Z, Dong Y, Maeda U, Moir R, Inouye SK, Culley DJ, Crosby G, Tanzi RE. Isoflurane-induced apoptosis: a potential pathogenic link between delirium and dementia. J Gerontol A Biol Sci Med Sci 2006;61:1300-6 (Pubitemid 46147786)
21. Lu Y, Wu X, Dong Y, Xu Z, Zhang Y, Xie Z. Anesthetic sevoflurane causes neurotoxicity differently in neonatal naive and Alzheimer disease transgenic mice. Anesthesiology 2010;112: 1404-16
22. Dong Y, Zhang G, Zhang B, Moir RD, Xia W, Marcantonio ER, Culley DJ, Crosby G, Tanzi RE, Xie Z. The common inhalational anesthetic sevoflurane induces apoptosis and increases beta-amyloid protein levels. Arch Neurol 2009;66:620-31
23. Zhen Y, Dong Y, Wu X, Xu Z, Lu Y, Zhang Y, Norton D, Tian M, Li S, Xie Z. Nitrous oxide plus isoflurane induces apoptosis and increases beta-amyloid protein levels. Anesthesiology 2009;111:741-52
24. Zhang B, Dong Y, Zhang G, Moir RD, Xia W, Yue Y, Tian M,Culley DJ, Crosby G, Tanzi RE, Xie Z. The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions. J Biol Chem 2008;283:11866-75
25. 2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochem J 1994;300:665-72
26. Bohnen NI, Warner MA, Kokmen E, Beard CM, Kurland LT. Alzheimers disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc 1994;42:198-201 (Pubitemid 24057360)
27. Bohnen N, Warner MA, Kokmen E, Kurland LT. Early and midlife exposure to anesthesia and age of onset of Alzheimers disease. Int J Neurosci 1994;77:181-5 (Pubitemid 2144593)
28. Lee TA, Wolozin B, Weiss KB, Bednar MM. Assessment of the emergence of Alzheimers disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis 2005;7:319-24 (Pubitemid 41206944)
29. Bufill E, Bartes A, Moral A, Casadevall T, Codinachs M, Zapater E, Carles Rovira J, Roura P, Oliva R, Blesa R. Genetic and environmental factors that may influence in the senile form of Alzheimers disease: nested case control studies [in Spanish]. Neurologia 2009;24:108-12
30. Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA. Coronary artery bypass grafting is not a risk factor for dementia or Alzheimer disease. Neurology 2005;65:986-90 (Pubitemid 41429619)
31. Gasparini M, Vanacore N, Schiaffini C, Brusa L, Panella M, Talarico G, Bruno G, Meco G, Lenzi GL. A case-control study on Alzheimers disease and exposure to anesthesia. Neurol Sci 2002;23:11-4 (Pubitemid 34591412)
32. Avidan MS, Searleman AC, Storandt M, Barnett K, Vannucci A, Saager L, Xiong C, Grant EA, Kaiser D, Morris JC, Evers AS. Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness. Anesthesiology 2009;111:964-70
33. Harris RA, Eger EI II. Alzheimers disease and anesthesia: out of body, out of mind or not? Ann Neurol 2008;64:595-7
34. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, Luo Y, Fisher S, Fuller J, Edenson S, Lile J, Jarosinski MA, Biere AL, Curran E, Burgess T, Louis JC, Collins F, Treanor J, Rogers G, Citron M. Beta-secretase cleavage of Alzheimers amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999;286:735-41
35. Wei H, Liang G, Yang H. Isoflurane preconditioning inhibited isoflurane-induced neurotoxicity. Neurosci Lett 2007;425:59-62 (Pubitemid 47411660)
36. Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, Danni O, Parola M, Smith MA, Perry G, Tamagno E, Tabaton M. The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha. J Neurochem 2009;108:1045-56
37. Costantini C, Weindruch R, Della Valle G, Puglielli L. A TrkA-to-p75NTR molecular switch activates amyloid beta peptide generation during aging. Biochem J 2005;391:5967
38. Guo ZH, Mattson MP. In vivo 2-deoxyglucose administration preserves glucose and glutamate transport and mitochondrial function in cortical synaptic terminals after exposure to amyloid beta-peptide and iron: evidence for a stress response. Exp Neurol 2000;166:173-9
39. Park M, Song KS, Kim HK, Park YJ, Kim HS, Bae MI, Lee J. 2-Deoxy-d-glucose protects neural progenitor cells against oxidative stress through the activation of AMP-activated protein kinase. Neurosci Lett 2009;449:201-6
40. OConnor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, Eimer WA, Hitt B, Bembinster LA, Lammich S, Lichtenthaler SF, Hebert SS, De Strooper B, Haass C, Bennett DA, Vassar R. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 2008;60:988-1009
41. Velliquette RA, OConnor T, Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimers disease pathogenesis. J Neurosci 2005;25:10874-83 (Pubitemid 41692617)